Published in Cancer Weekly, August 25th, 2009
Gerd Gigerenzer, of the Max Planck Institute for Human Development in Berlin, and colleagues conducted a survey of over 10,200 people from nine European countries to assess perceptions of cancer-specific mortality reduction associated with mammography and prostate-specific antigen screening, and to determine the sources of information they rely on.
The authors found that the majority of participants...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.